33
Participants
Start Date
March 1, 2024
Primary Completion Date
November 4, 2024
Study Completion Date
November 25, 2024
Placebo
Matching placebo SC injection
R2R01
Pharmaceutical Form: sterile 2R vials containing 10 mg of R2R01 for SC injection.
Hospital of the University of Pennsylvania, Philadelphia
Piedmont Hospital Transplant, Atlanta
Mayo Clinic, Jacksonville
Vanderbilt University Medical Center, Nashville
University of Michigan Medical Center, Ann Arbor
Mayo Clinic, Rochester
Rush University Medical Center, Chicago
Ochsner Clinic Foundation, New Orleans
VA North Texas Health Care, Dallas
Baylor Scott and White All Saints Medical Center, Fort Worth
Mayo Clinic, Phoenix
California Pacific Medical Center, San Francisco
Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
University of Duisburg-Essen, Essen
University of Munster, Münster
University of Bologna, Bologna
University-Hospital of Padova, Padua
International HealthCare, LLC
OTHER
River 2 Renal Corp.
INDUSTRY